lrcx-20220420
false000070754900007075492022-04-202022-04-20
Table of Contents
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM 8-K
 Current Report
Pursuant to Section 13 or 15(d)
of the Securities Exchange Act of 1934
Date of report (Date of earliest event reported): April 20, 2022
  LAM RESEARCH CORPORATION
(Exact name of registrant as specified in its charter)
 
Delaware 0-12933 94-2634797
(State or Other Jurisdiction
of Incorporation)		 (Commission
File Number)		 (IRS Employer
Identification Number)
4650 Cushing Parkway
Fremont, California 94538
(Address of principal executive offices including zip code)
(510) 572-0200
(Registrant’s telephone number, including area code)
Not Applicable
(Former name or former address, if changed since last report)
Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions (see General Instruction A.2. below):
☐Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
☐Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
☐Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
☐Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))
Securities registered pursuant to Section 12(b) of the Act:
Title of each classTrading SymbolName of each exchange on which registered
Common Stock, Par Value $0.001 Per ShareLRCXThe Nasdaq Stock Market
(Nasdaq Global Select Market)
Indicate by check mark whether the registrant is an emerging growth company as defined in as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter).
Emerging growth company      ☐
If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act.                      ☐

Table of Contents
Table of Contents
 
Item 2.02.  Results of Operations and Financial Condition 
Item 9.01.  Financial Statements and Exhibits 
SIGNATURES 
EX-99.1

Table of Contents
 Item 2.02.Results of Operations and Financial Condition
On April 20, 2022, Lam Research Corporation (the “Company”) issued a press release announcing its financial results for the fiscal quarter ended March 27, 2022, the text of which is attached hereto as Exhibit 99.1.
The information in this item of this Current Report on Form 8-K, including Exhibit 99.1, is furnished pursuant to Item 2.02 and shall not be deemed “filed” for the purposes of Section 18 of the Securities Exchange Act of 1934, as amended (the “Exchange Act”), or otherwise subject to the liabilities under that Section. Furthermore, the information in this item of this Current Report on Form 8-K, including Exhibit 99.1, shall not be deemed to be incorporated by reference into the filings of the Company under the Securities Act of 1933, as amended, or the Exchange Act.
 Item 9.01.Financial Statements and Exhibits
(d) Exhibits
99.1
104Cover Page Interactive Data File - the cover page XBRL tags are embedded within the Inline XBRL document

Table of Contents
SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.
Date:April 20, 2022
LAM RESEARCH CORPORATION
(Registrant)
 /s/ Douglas R. Bettinger
 Douglas R. Bettinger
 Executive Vice President, Chief Financial Officer
 (Principal Financial Officer and Principal Accounting Officer)
 



Exhibit 99.1
FOR IMMEDIATE RELEASE        
Lam Research Corporation Reports Financial Results for the Quarter Ended March 27, 2022
FREMONT, Calif., April 20, 2022 - Lam Research Corporation (the "Company," "Lam," "Lam Research") today announced financial results for the quarter ended March 27, 2022 (the “March 2022 quarter”).
Highlights for the March 2022 quarter were as follows:
•Revenue of $4.06 billion.
•U.S. GAAP gross margin of 44.7%, U.S. GAAP operating income as a percentage of revenue of 29.4%, and U.S. GAAP diluted EPS of $7.30.
•Non-GAAP gross margin of 44.7%, non-GAAP operating income as a percentage of revenue of 29.4%, and non-GAAP diluted EPS of $7.40.
Key Financial Data for the Quarters Ended
March 27, 2022 and December 26, 2021
(in thousands, except per-share data, percentages, and basis points) 
U.S. GAAP
   March 2022December 2021Change Q/Q
Revenue  $4,060,416 $4,226,604 - 4%
Gross margin as percentage of revenue  44.7 %46.8 %- 210 bps
Operating income as percentage of revenue  29.4 %31.7 %- 230 bps
Diluted EPS  $7.30 $8.44 - 14%
Non-GAAP
   March 2022December 2021Change Q/Q
Revenue  $4,060,416 $4,226,604 - 4%
Gross margin as percentage of revenue  44.7 % 46.8 %- 210 bps
Operating income as percentage of revenue  29.4 % 32.0 %- 260 bps
Diluted EPS  $7.40  $8.53 - 13%

U.S. GAAP Financial Results
For the March 2022 quarter, revenue was $4,060 million, gross margin was $1,817 million, or 44.7% of revenue, operating expenses were $625 million, operating income was 29.4% of revenue, and net income was $1,022 million, or $7.30 per diluted share on a U.S. GAAP basis. This compares to revenue of $4,227 million, gross margin of $1,978 million, or 46.8% of revenue, operating expenses of $640 million, operating income of 31.7% of revenue, and net income of $1,195 million, or $8.44 per diluted share, for the quarter ended December 26, 2021 (the “December 2021 quarter”).
Non-GAAP Financial Results
For the March 2022 quarter, non-GAAP gross margin was $1,815 million, or 44.7% of revenue, non-GAAP operating expenses were $621 million, non-GAAP operating income was 29.4% of revenue, and non-GAAP net income was $1,036 million, or $7.40 per diluted share. This compares to non-GAAP gross margin of $1,979 million, or 46.8% of revenue, non-GAAP operating expenses of $627 million, non-GAAP operating income of 32.0% of revenue, and non-GAAP net income of $1,207 million, or $8.53 per diluted share, for the December 2021 quarter.

“In an extraordinarily difficult supply environment, Lam reported March quarter results within guided ranges,” said Tim Archer, Lam Research’s President and Chief Executive Officer. “We are focused on resolving our supply issues as quickly as possible to support strong customer demand. We remain confident in the secular drivers of wafer fabrication equipment investment as well as Lam's leadership position and expect to return to solid growth as industry constraints ease.”





Balance Sheet and Cash Flow Results
Cash and cash equivalents, short-term investments, and restricted cash and investments balances decreased to $4.6 billion at the end of the March 2022 quarter compared to $5.6 billion at the end of the December 2021 quarter. This decrease was primarily the result of $1.3 billion of share repurchases, including net share settlement of employee stock-based compensation; $211 million of dividends paid to stockholders; and $145 million of capital expenditures, partially offset by $758 million of cash generated from operating activities.
Deferred revenue at the end of the March 2022 quarter increased to $2,069 million compared to $1,458 million as of the end of the December 2021 quarter. Lam's deferred revenue balance does not include shipments to customers in Japan, to whom title does not transfer until customer acceptances. Shipments to customers in Japan are classified as inventory at cost until the time of acceptance. The estimated future revenue from shipments to customers in Japan was approximately $263 million as of March 27, 2022 and $328 million as of December 26, 2021.
Revenue
The geographic distribution of revenue during the March 2022 quarter is shown in the following table:
RegionRevenue
China31%
Korea24%
Taiwan16%
Japan9%
Southeast Asia9%
United States8%
Europe3%
The following table presents revenue disaggregated between system and customer support-related revenue:
Three Months Ended
March 27,
2022		December 26,
2021		March 28,
2021
(In thousands)
System revenue$2,650,842 $2,740,173 $2,545,306 
Customer support-related revenue and other1,409,574 1,486,431 1,302,348 
$4,060,416 $4,226,604 $3,847,654 
System revenue includes sales of new leading-edge equipment in deposition, etch and clean markets.
Customer support-related revenue includes sales of customer service, spares, upgrades, and non-leading-edge equipment from our Reliant® product line.
Outlook

For the quarter ended June 26, 2022, Lam is providing the following guidance:

U.S. GAAPReconciling ItemsNon-GAAP
Revenue$4.20 Billion+/-$300 Million—$4.20 Billion+/-$300 Million
Gross margin as a percentage of revenue44.5%+/-1%$1 Million44.5%+/-1%
Operating income as a percentage of revenue29.2%+/-1%$11 Million29.5%+/-1%
Net income per diluted share$7.18+/-$0.75$10 Million$7.25+/-$0.75
Diluted share count139 Million—139 Million
The information provided above is only an estimate of what the Company believes is realizable as of the date of this release and does not incorporate the potential impact of any business combinations, asset acquisitions, divestitures, restructuring, balance sheet valuation adjustments, financing arrangements, other investments, or other significant arrangements that may be completed or recognized after the date of this release. U.S. GAAP to non-GAAP reconciling items provided include only those items that are known and can be estimated as


of the date of this release. Actual results will vary from this model and the variations may be material. Reconciling items included above are as follows:

•Gross margin as a percentage of revenue - amortization related to intangible assets acquired through business combinations, $1 million.

•Operating income as a percentage of revenue - amortization related to intangible assets acquired through business combinations, $11 million.

•Net income per diluted share - amortization related to intangible assets acquired though business combinations, $11 million; amortization of note discounts, $1 million; and associated tax benefit for non-GAAP items ($2 million); totaling $10 million.
Use of Non-GAAP Financial Results
In addition to U.S. GAAP results, this press release also contains non-GAAP financial results. The Company’s non-GAAP results for both the March 2022 and December 2021 quarters exclude amortization related to intangible assets acquired through business combinations, the effects of elective deferred compensation-related assets and liabilities, amortization of note discounts, and the net income tax benefit of non-GAAP items.
Management uses non-GAAP gross margin, operating expense, operating income, operating income as a percentage of revenue, net income, and net income per diluted share to evaluate the Company’s operating and financial results. The Company believes the presentation of non-GAAP results is useful to investors for analyzing business trends and comparing performance to prior periods, along with enhancing investors’ ability to view the Company’s results from management’s perspective. Tables presenting reconciliations of non-GAAP results to U.S. GAAP results are included at the end of this press release and on the Company’s website at http://investor.lamresearch.com.
Caution Regarding Forward-Looking Statements
Statements made in this press release that are not of historical fact are forward-looking statements and are subject to the safe harbor provisions created by the Private Securities Litigation Reform Act of 1995. Such forward-looking statements relate to, but are not limited to: our outlook and guidance for future financial results, including revenue, gross margin, operating income and net income; customer and industry investment and demand for wafer fabrication equipment and for our products; supply chain conditions and other industry constraints, our efforts to address them and the timing for doing so, and the impacts on our results; and our position in the industry and prospects for growth. Some factors that may affect these forward-looking statements include: supply chain disruptions have limited and are expected to continue to limit our ability to meet demand for our products; supply chain cost increases and other inflationary pressures have impacted and are expected to continue to impact our profitability; trade regulations, export controls, trade disputes, and other geopolitical tensions may inhibit our ability to sell our products; business, political and/or regulatory conditions in the consumer electronics industry, the semiconductor industry and the overall economy may deteriorate or change; the actions of our customers and competitors may be inconsistent with our expectations; the severity, magnitude and duration of the COVID–19 pandemic (and the related governmental, public health, business and community responses to it), and their impacts on our business, results of operations and financial condition, are evolving and are highly uncertain and unpredictable; and widespread outbreaks of illness may impact our operations and revenue in affected areas; as well as the other risks and uncertainties that are described in the documents filed or furnished by us with the Securities and Exchange Commission, including specifically the Risk Factors described in our annual report on Form 10–K for the fiscal year ended June 27, 2021 and our quarterly report on Form 10-Q for the fiscal quarter ended December 26, 2021. These uncertainties and changes could materially affect the forward-looking statements and cause actual results to vary from expectations in a material way. The Company undertakes no obligation to update the information or statements made in this release.

Lam Research Corporation is a global supplier of innovative wafer fabrication equipment and services to the semiconductor industry. Lam's equipment and services allow customers to build smaller and better performing devices. In fact, today, nearly every advanced chip is built with Lam technology. We combine superior systems engineering, technology leadership, and a strong values-based culture, with an unwavering commitment to our customers. Lam Research (Nasdaq: LRCX) is a FORTUNE 500® company headquartered in Fremont, Calif., with operations around the globe. Learn more at www.lamresearch.com. (LRCX-F)
Consolidated Financial Tables Follow.
 ###




 
LAM RESEARCH CORPORATION
CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS
(in thousands, except per share data and percentages)
(unaudited) 
 Three Months EndedNine Months Ended
 March 27,
2022		December 26,
2021		March 28,
2021		March 27,
2022		March 28,
2021
Revenue$4,060,416 $4,226,604 $3,847,654 $12,591,485 $10,480,971 
Cost of goods sold2,243,791 2,248,688 2,067,523 6,820,190 5,590,866 
Gross margin1,816,625 1,977,916 1,780,131 5,771,295 4,890,105 
Gross margin as a percent of revenue44.7 %46.8 %46.3 %45.8 %46.7 %
Research and development407,120 403,644 381,120 1,193,091 1,111,659 
Selling, general and administrative217,408 236,133 203,703 675,735 612,350 
Total operating expenses624,528 639,777 584,823 1,868,826 1,724,009 
Operating income1,192,097 1,338,139 1,195,308 3,902,469 3,166,096 
Operating income as a percent of revenue29.4 %31.7 %31.1 %31.0 %30.2 %
Other income (expense), net(57,402)17,999 (35,320)(68,260)(104,053)
Income before income taxes1,134,695 1,356,138 1,159,988 3,834,209 3,062,043 
Income tax expense(112,917)(161,308)(88,867)(437,857)(298,242)
Net income$1,021,778 $1,194,830 $1,071,121 $3,396,352 $2,763,801 
Net income per share:
Basic$7.34 $8.50 $7.51 $24.17 $19.20 
Diluted$7.30 $8.44 $7.41 $24.02 $18.94 
Number of shares used in per share calculations:
Basic139,229 140,630 142,676 140,534 143,925 
Diluted140,057 141,530 144,609 141,400 145,923 
Cash dividend declared per common share$1.50 $1.50 $1.30 $4.50 $3.90 
 














 LAM RESEARCH CORPORATION
CONDENSED CONSOLIDATED BALANCE SHEETS
(in thousands)
 
March 27,
2022		December 26,
2021		June 27,
2021
(unaudited)(unaudited)(1)
ASSETS
Cash and cash equivalents$4,194,719 $5,086,544 $4,418,263 
Investments160,072 242,590 1,310,872 
Accounts receivable, net3,702,320 3,402,840 3,026,430 
Inventories3,479,332 3,074,177 2,689,294 
Prepaid expenses and other current assets351,658 296,711 207,528 
Total current assets11,888,101 12,102,862 11,652,387 
Property and equipment, net1,561,875 1,503,385 1,303,479 
Restricted cash and investments251,036 250,863 252,487 
Goodwill and intangible assets1,627,035 1,601,755 1,622,499 
Other assets1,260,984 1,226,563 1,061,300 
Total assets$16,589,031 $16,685,428 $15,892,152 
LIABILITIES AND STOCKHOLDERS’ EQUITY
Current portion of long-term debt and finance lease obligations$7,689 $6,201 $11,349 
Other current liabilities4,187,052 3,856,950 3,516,518 
Total current liabilities4,194,741 3,863,151 3,527,867 
Long-term debt and finance lease obligations5,000,657 4,988,121 4,990,333 
Income taxes payable916,668 891,545 948,037 
Other long-term liabilities450,475 466,830 398,727 
Total liabilities10,562,541 10,209,647 9,864,964 
Stockholders’ equity (2)6,026,490 6,475,781 6,027,188 
Total liabilities and stockholders’ equity$16,589,031 $16,685,428 $15,892,152 
 
(1)Derived from audited financial statements.
(2)
Common shares issued and outstanding were 138,707 as of March 27, 2022, 140,275 as of December 26, 2021, and 142,501 as of June 27, 2021.
 




 
LAM RESEARCH CORPORATION
CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS
(in thousands, unaudited)
 Three Months EndedNine Months Ended
 March 27,
2022		December 26,
2021		March 28,
2021		March 27,
2022		March 28,
2021
CASH FLOWS FROM OPERATING ACTIVITIES:
Net income$1,021,778 $1,194,830 $1,071,121 $3,396,352 $2,763,801 
Adjustments to reconcile net income to net cash provided by operating activities:
Depreciation and amortization84,228 81,705 79,453 245,807 228,754 
Deferred income taxes(56,878)(13,550)(1,136)(83,451)(5,448)
Equity-based compensation expense68,543 62,834 55,746 189,476 163,843 
Other, net(3,121)(66,514)(635)(78,325)10,394 
Changes in operating assets and liabilities(356,840)181,201 (39,469)(1,014,119)(1,009,116)
Net cash provided by operating activities757,710 1,440,506 1,165,080 2,655,740 2,152,228 
CASH FLOWS FROM INVESTING ACTIVITIES:
Capital expenditures and intangible assets(145,368)(138,493)(89,596)(420,288)(244,474)
Net sale (purchase) of available-for-sale securities79,184 325,171 233,529 1,142,398 (335,443)
Other, net(28,380)(595)(27,997)(33,898)(35,873)
Net cash (used for) provided by investing activities(94,564)186,083 115,936 688,212 (615,790)
CASH FLOWS FROM FINANCING ACTIVITIES:
Principal payments on debt(1,821)(1,698)(16,245)(9,857)(40,014)
Treasury stock purchases(1,338,006)(414,815)(1,094,571)(2,989,574)(2,266,449)
Dividends paid(210,587)(211,216)(186,551)(607,234)(541,607)
Reissuance of treasury stock related to employee stock purchase plan— 46,380 — 46,380 41,434 
Proceeds from issuance of common stock492 3,451 9,626 4,685 23,272 
Other, net214 (205)(665)197 (1,844)
Net cash used for financing activities(1,549,708)(578,103)(1,288,406)(3,555,403)(2,785,208)
Effect of exchange rate changes on cash, cash equivalents, and restricted cash(5,090)(4,678)(5,756)(13,544)6,513 
Net (decrease) increase in cash, cash equivalents, and restricted cash(891,652)1,043,808 (13,146)(224,995)(1,242,257)
Cash, cash equivalents, and restricted cash at beginning of period5,337,407 4,293,599 3,939,972 4,670,750 5,169,083 
Cash, cash equivalents, and restricted cash at end of period$4,445,755 $5,337,407 $3,926,826 $4,445,755 $3,926,826 



 
Non-GAAP Financial Summary
(in thousands, except percentages and per share data)
(unaudited)
Three Months Ended
March 27,
2022		December 26,
2021
Revenue$4,060,416 $4,226,604 
Gross margin$1,814,910 $1,979,000 
Gross margin as percentage of revenue44.7 %46.8 %
Operating expenses$620,636 $627,445 
Operating income$1,194,274 $1,351,555 
Operating income as a percentage of revenue29.4 %32.0 %
Net income$1,036,359 $1,207,340 
Net income per diluted share$7.40 $8.53 
Shares used in per share calculation - diluted140,057 141,530 
Reconciliation of U.S. GAAP Net Income to Non-GAAP Net Income
(in thousands, except per share data)
(unaudited) 
Three Months Ended
March 27,
2022		December 26,
2021
U.S. GAAP net income$1,021,778 $1,194,830 
Pre-tax non-GAAP items:
Amortization related to intangible assets acquired through certain business combinations - cost of goods sold1,153 1,092 
Elective deferred compensation ("EDC") related liability valuation decrease - cost of goods sold(2,868)(8)
EDC related liability valuation decrease - research and development(5,161)(15)
Amortization related to intangible assets acquired through certain business combinations - selling, general and administrative12,494 12,357 
EDC related liability valuation decrease - selling, general and administrative(3,441)(10)
Amortization of note discounts - other income (expense), net695 689 
Loss on EDC related asset - other income (expense), net13,118 56 
Net income tax benefit on non-GAAP items(1,409)(1,651)
Non-GAAP net income$1,036,359 $1,207,340 
Non-GAAP net income per diluted share$7.40 $8.53 
U.S. GAAP net income per diluted share$7.30 $8.44 
U.S. GAAP and non-GAAP number of shares used for per diluted share calculation140,057 141,530 



 
Reconciliation of U.S. GAAP Gross Margin, Operating Expenses and Operating Income to Non-GAAP Gross Margin, Operating Expenses and Operating Income
(in thousands, except percentages)
(unaudited) 
Three Months Ended
March 27,
2022		December 26,
2021
U.S. GAAP gross margin$1,816,625 $1,977,916 
Pre-tax non-GAAP items:
Amortization related to intangible assets acquired through certain business combinations1,153 1,092 
EDC related liability valuation decrease(2,868)(8)
Non-GAAP gross margin$1,814,910 $1,979,000 
U.S. GAAP gross margin as a percentage of revenue44.7 %46.8 %
Non-GAAP gross margin as a percentage of revenue44.7 %46.8 %
U.S. GAAP operating expenses$624,528 $639,777 
Pre-tax non-GAAP items:
Amortization related to intangible assets acquired through certain business combinations(12,494)(12,357)
EDC related liability valuation decrease8,602 25 
Non-GAAP operating expenses$620,636 $627,445 
U.S. GAAP operating income$1,192,097 $1,338,139 
Non-GAAP operating income$1,194,274 $1,351,555 
U.S. GAAP operating income as percent of revenue29.4 %31.7 %
Non-GAAP operating income as a percent of revenue29.4 %32.0 %
 
Lam Research Corporation Contacts:
Tina Correia, Investor Relations, phone: 510-572-1615, e-mail: [email protected]